What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.90%Below 5Y avg (2.25%)
Annual Rate
CNY 0.11Paid annual
Payout Ratio
41.6%Sustainable
Last Ex-Dividend
Jun 26, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.28BCNY
784.59M · vs all stocks (USD)
Updated Aug 21, 2026
Trailing P/E
33.42x
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Revenue (TTM)
5.08BCNY
755.07M · vs all stocks (USD)
Updated Aug 21, 2026
Profit Margin
3.09%
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Beta
0.5520x
vs all stocks
Updated Aug 21, 2026
52-Week Change
-34.48%
vs all stocks
Updated Aug 21, 2026
Market Capitalization
5.28BCNY
784.59M · vs all stocks (USD)
Updated Aug 21, 2026
Enterprise Value
5.46BCNY
812.00M · vs all stocks (USD)
Updated Aug 21, 2026
Trailing P/E
33.42x
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Forward P/E
23.09x
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
PEG Ratio
5.01x
Updated Aug 21, 2026
Price to Sales (TTM)
1.04x
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Price to Book (MRQ)
1.51x
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Enterprise to Revenue
1.07x
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Enterprise to EBITDA
9.97x
vs Pollution & Treatment Controls peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 7.86×.Updated Aug 21, 2026
Gross Margin
26.28%
vs Pollution & Treatment Controls peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 23.15%.Updated Aug 21, 2026
Profit Margin
3.09%
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Operating Margin
9.47%
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Return on Assets (TTM)
2.79%
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Return on Equity (TTM)
5.28%
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Revenue (TTM)
5.08BCNY
755.07M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue per Share (TTM)
12.11CNYUpdated Aug 21, 2026
Quarterly Revenue Growth
13.00%
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Gross Profit (TTM)
1.18BCNY
174.78M · vs all stocks (USD)
Updated Aug 21, 2026
EBITDA (TTM)
694.92MCNY
103.34M · vs all stocks (USD)
Updated Aug 21, 2026
Net Income (TTM)
156.97MCNY
23.34M · vs all stocks (USD)
Updated Aug 21, 2026
Quarterly Earnings Growth (YoY)
2.80%
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Operating Cash Flow (TTM)
452.25MCNY
67.25M · vs all stocks (USD)
Updated Aug 21, 2026
Levered Free Cash Flow (TTM)
150.27MCNY
22.35M · vs all stocks (USD)
Updated Aug 21, 2026
Trailing Annual Dividend Rate
0.1130CNYUpdated Aug 21, 2026
Trailing Annual Dividend Yield
0.90%
vs all stocks
Updated Aug 21, 2026
5-Year Average Dividend Yield
2.25%
vs all stocks
Updated Aug 21, 2026
Payout Ratio
41.58%
vs Pollution & Treatment Controls peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 29.74%.Updated Aug 21, 2026
Minority Interest (Equity)
394.83MCNYFY2025 · Dec 31, 2025
Revenue
4.93BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
3.81BCNYFY2025 · Dec 31, 2025
Gross Profit
1.12BCNYFY2025 · Dec 31, 2025
Operating Income
440.06MCNY
65.44M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
301.37MCNYFY2025 · Dec 31, 2025
Income Tax Expense
95.10MCNYFY2025 · Dec 31, 2025
Net Income
206.27MCNYFY2025 · Dec 31, 2025
EBIT
330.40MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
694.92MCNYFY2025 · Dec 31, 2025
Research & Development
100.57MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
299.89MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
30.79MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
9.14MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
29.03MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.3700CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.3700CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
419.38MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
419.38MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
206.27MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-51.10MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-133.22MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-338.07MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
762.50MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
206.27MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
62.02MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-381.14MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-20.38MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-204.85MCNYFY2025 · Dec 31, 2025
Sale of Investments
14.38MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-74.19MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-264.65MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
607.18MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-579.19MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-87.06MCNYFY2025 · Dec 31, 2025
Other Financing Charges
20.30MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-38.77MCNYFY2025 · Dec 31, 2025
Shares Outstanding
415.43MSharesUpdated Aug 21, 2026
Float Shares
325.03MSharesUpdated Aug 21, 2026
% Held by Insiders
23.30%
vs all stocks
Updated Aug 21, 2026
% Held by Institutions
0.71%
vs all stocks
Updated Aug 21, 2026
Total Cash (MRQ)
1.03BCNY
153.56M · vs all stocks (USD)
Updated Aug 21, 2026
Total Cash per Share (MRQ)
2.49CNYUpdated Aug 21, 2026
Total Debt (MRQ)
824.11MCNY
122.55M · vs all stocks (USD)
Updated Aug 21, 2026
Total Debt to Equity (MRQ)
0.2108x
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Current Ratio (MRQ)
1.85x
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Book Value per Share (MRQ)
8.43CNYUpdated Aug 21, 2026
Total Assets
7.17BCNY
1.07B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
5.37BCNYFY2025 · Dec 31, 2025
Total Liabilities
3.34BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.80BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
451.57MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
2.88BCNYFY2025 · Dec 31, 2025
Cash
772.96MCNYFY2025 · Dec 31, 2025
Cash Equivalents
91.39MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
864.48MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
232.16MCNYFY2025 · Dec 31, 2025
Accounts Receivable
2.73BCNYFY2025 · Dec 31, 2025
Inventory
272.92MCNYFY2025 · Dec 31, 2025
Accounts Payable
1.61BCNYFY2025 · Dec 31, 2025
Short-term Debt
430.73MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
18.83MCNYFY2025 · Dec 31, 2025
Long-term Debt
380.11MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
415.43MCNYFY2025 · Dec 31, 2025
Retained Earnings
1.96BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.83BCNY
569.55M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
11.49CNYUpdated Aug 21, 2026
52-Week High
36.65CNYUpdated Aug 21, 2026
52-Week Change
-34.48%
vs all stocks
Updated Aug 21, 2026
Beta
0.5520x
vs all stocks
Updated Aug 21, 2026
50-Day MA
13.13CNYUpdated Aug 21, 2026
200-Day MA
20.30CNYUpdated Aug 21, 2026
Avg 10-Day Volume
9.27MSharesUpdated Aug 21, 2026
Avg 30-Day Volume
12.84MSharesUpdated Aug 21, 2026
Diluted EPS (TTM)
0.3800CNYUpdated Aug 21, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
How is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Where is this company structurally exposed?
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.